Skip to main content Accessibility help

Outbreak of Fluoroquinolone-Resistant Escherichia coli Infections after Transrectal Ultrasound—Guided Biopsy of the Prostate

  • Donald Dumford (a1), Nuntra Suwantarat (a1), Vineet Bhasker (a1), Sirisha Kundrapu (a2), Trina F. Zabarsky (a3), Paul Drawz (a2), Hui Zhu (a2) (a4) and Curtis J. Donskey (a2) (a5)...



We conducted an investigation after identifying a cluster of 4 serious infections following transrectal ultrasound–guided biopsy of the prostate (TRUBP) during a 2-month period.


veterans Affairs medical center.


Patients with urinary tract infection (UTI) after TRUBP and time-matched controls with no evidence of infection.


The incidence of UTI within 30 days after TRUBP was calculated from 2002 through 2010. We evaluated the correlation between infection with fluoroquinolone-resistant gram-negative bacilli (GNB) and fluoroquinolone resistance in outpatient Escherichia coli urinary isolates and performed a case-control study to determine risk factors for infection with fluoroquinolone-resistant GNB. Processes for TRUBP prophylaxis, procedures, and equipment sterilization were reviewed.


An outbreak of UTI due to fluoroquinolone-resistant E. coli after TRUBP began 2 years before the cluster was identified and was correlated with increasing fluoroquinolone resistance in outpatient E. coli. No deficiencies were identified in equipment processing or biopsy procedures. Fluoroquinolone-resistant E. coli UTI after TRUBP was independently associated with prior infection with fluoroquinolone-resistant GNB (adjusted odds ratio, 20.8; P = .005). A prediction rule including prior UTI, hospitalization in the past year, and previous infection with fluoroquinolone-resistant GNB identified only 17 (49%) of 35 cases.


The outbreak of fluoroquinolone-resistant E. coli infections after TRUBP closely paralleled rising rates of fluoroquinolone resistance among outpatient E. coli isolates. The delayed detection of the outbreak and the absence of sensitive predictors of infection suggest that active surveillance for infection after TRUBP is necessary in the context of increasing fluoroquinolone resistance in the United States.


Corresponding author

Geriatric Research, Education, and Clinical Center 1110W, Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106 (


Hide All
1. Loeb, S, Carter, HB, Brendt, SI, Ricker, W, Shaeffer, EM. Complications after prostate biopsy: data from SEER-Medicine. J Urol 2011;186:18301834.
2. Gillespie, J, Arnold, KE, Kainer, MA, et al. Pseudomonas aeruginosa infections associated with transrectal ultrasound-guided prostate biopsies—Georgia, 2005. MMWR Morb Mortal Wkly Rep 2006;55:776777.
3. Rietbergen, JBW, Boeken Krufer, AE, Kranse, R, Schroder, FH. Complications of transrectal ultrasound-guided systemic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997;49:875880.
4. Otrock, ZK, Oghlakian, GO, Salamoun, MM, Haddad, M, Bizri, ARN. Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon. Infect Control Hosp Epidemiol 2004;25:873877.
5. Shigemura, K, Miyagi, T, Nakashima, T, Shimamura, M. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 2008;14:4043.
6. Kim, SJ, Kim, SI, Ahn, HS, Choi, JB, Kim, YS, Kim, SJ. Risk factors for acute prostatitis after transrectal biopsy of the prostate. Korean J Urol 2010;51:426430.
7. Hadway, P, Barrett, LK, Waghorn, DJ, et al. Urosepsis and bacteremia caused by antibiotic-resistant organisms after transrectal ultrasonography-guided prostate biopsy. BJU Int 2009; 104:15561558.
8. Zaytoun, OM, Vargo, EN, Rajan, R, Berglund, R, Gordon, S, Jones, JS. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 2011;77:10351042.
9. Mosharafa, AA, Torky, MH, El Said, WM, Meshref, A. Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor. Urology 2011;78:511514.
10. Hedelin, H, Claesson, BE, Wilpart, A. Febrile reactions after transrectal ultrasound-guided prostatic biopsy: a retrospective study. Scand J Urol Nephrol 2011;45:393396.
11. Zani, EL, Clark, OA, Rodrigues Netto, N Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev 2011; 11:CD006576.
12. Wolf, JS Jr, Bennett, CJ, Dmochowski, RR, Hollenbeck, BK, Pearle, MS, Shaeffer, AJ; Urologie Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologie surgery antimicrobial prophylaxis. J Urol 2008; 179: 13791390.
13. Johnson, L, Sabel, A, Burman, WJ, et al. Emergence of fluoro-quinone resistance in outpatient urinary Escherichia coli isolates. Am f Med 2008;121:876884.
14. Feliciano, J, Teper, E, Ferrandino, M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy—are fluoroquinolones still effective prophylaxis? J Urol 2008; 179:952955.
15. Young, JL, Liss, MA, Szabo, RJ. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Urology 2009;74:332339.
16. Nam, RK, Saskin, R, Lee, Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010;183:963968.
17. Liss, MA, Chang, A, Santos, R, et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 2011;185:12831288.
18. Ho, HS, Ng, LG, Tan, YH, Yeo, M, Cheng, CW. Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy. Ann Acad Med Singapore 2009;38:212216.
19. Madden, T, Doble, A, Aliyu, SH, Neal, DE. Infective complications after transrectal ultrasound-guided prostate biopsy following a new protocol for antibiotic prophylaxis aimed at reducing hospital-acquired infections. BJU Int 2011;108:15971602.
20. Hori, S, Sengupta, A, Joannides, A, Balogun-Ojuri, B, Tilley, R, McLoughlin, J. Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk? BJU Int 2010;106:12981302.
21. Fraschini, F, Scaglione, F, Falchi, M, et al. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. J Chemother 1999;2:171177.
22. Batura, D, Rao, GG, Nielsen, PB. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int 2010;106:10171020.
23. Taylor, AK, Zembower, TR, Nadler, RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 2012;187:12751279.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed